BBLNF — Babylon Holdings Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $270.17m
- $1.11bn
Annual income statement for Babylon Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | IFRS | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 16 | 79.3 | 321 | 1,110 |
| Cost of Revenue | ||||
| Gross Profit | -3.78 | — | — | — |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Depreciation and Amortization | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 179 | 280 | 630 | 1,479 |
| Operating Profit | -163 | -201 | -309 | -370 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -146 | -208 | -84.9 | -222 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -140 | -213 | -83.4 | -221 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | -140 | -212 | -77.4 | -221 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -140 | -212 | -77.4 | -221 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -7.95 | -12 | -4.83 | -9.75 |
| Dividends per Share |